Unit Code 80141:
Vancomycin, Peak/Post
Method Description
Enzyme-multiplied immunoassay technique (EMIT) is performed
using the Olympus analyzer. EMIT offers an alternative to the
traditional spectroscopic and chromatographic method for
quantitating blood concentrations of drugs. The technique for
drugs is based upon an enzymatic assay for glucose-6-phosphate
dehydrogenase, using spectral properties at 340 nm, in which the
reduction of nicotinamide adenine dinucleotide (NAD) substrate is
monitored. The basis of the drug detection technique is an
immunological reaction between the drug and a specific antibody.
The reagent contains the enzyme (glucose-6-phosphate dehydrogenase)
to which the drug is covalently bound and an antibody specific to the
drug. The antibody binds most of the drug-bound enzyme, rendering
the enzyme inactive. This results in a baseline enzymatic activity.
In the presence of free drug, antibody equilibrates between free drug
and enzyme-bound drug leaving some of the drug-bound enzyme
uncomplexed and able to catalyze the reaction. If more free drug is
introduced, either as standard or sample, then competition for the
antibody takes place between the drug in the sample and the drug
attached to the enzyme. This results in more drug-bound enzyme being
left uncomplexed and able to catalyze the enzyme reaction at a greater
rate as compared to the baseline activity. The observed enzyme activity
increases with the amount of total free drug in the sample. (Moyer TP:
Therapeutic drug monitoring. In Tietz Textbook of Clinical Chemistry.
4th edition. Edited by CA Burtis, ER Ashwood. Philadelphia, WB Saunders
Company, 2005, pp 1237-1285)
Performing Laboratory Location
Rochester


